Jonathan Stewart

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Devices

Placebos

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Agosti Vito; Hellerstein David J; Stewart Jonathan W
Does personality disorder decrease the likelihood of remission in early-onset chronic depression?
Stewart Jonathan W; McGrath Patrick J; Deliyannides Rodeborah A; Quitkin Frederic M
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
Zisook Sidney; Trivedi Madhukar H; Warden Diane; Lebowitz Barry; Thase Michael E; Stewart Jonathan W; Moutier Christine; Fava Maurizio; Wisniewski Stephen R; Luther James; Rush A John
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jonathan Stewart (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Agosti Vito; Hellerstein David J; Stewart Jonathan W
Does personality disorder decrease the likelihood of remission in early-onset chronic depression?
Comprehensive psychiatry 2009;50(6):491-5.
2009: Stewart Jonathan W; McGrath Patrick J; Deliyannides Rodeborah A; Quitkin Frederic M
Does dual antidepressant therapy as initial treatment hasten and increase remission from depression?
Journal of psychiatric practice 2009;15(5):337-45.
2009: Zisook Sidney; Trivedi Madhukar H; Warden Diane; Lebowitz Barry; Thase Michael E; Stewart Jonathan W; Moutier Christine; Fava Maurizio; Wisniewski Stephen R; Luther James; Rush A John
Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.
Journal of affective disorders 2009;117(1-2):63-73.
2008: McGrath Patrick J; Khan Ahsan Y; Trivedi Madhukar H; Stewart Jonathan W; Morris David W; Wisniewski Stephen R; Miyahara Sachiko; Nierenberg Andrew A; Fava Maurizio; Rush John A
Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.
The Journal of clinical psychiatry 2008;69(12):1847-55.
2008: Stewart Jonathan W; Deliyannides Deborah A; McGrath Patrick J
Is duloxetine effective treatment for depression with atypical features?
International clinical psychopharmacology 2008;23(6):333-6.
2008: Gorlyn Marianne; Keilp John G; Grunebaum Michael F; Taylor Bonnie P; Oquendo Maria A; Bruder Gerard E; Stewart Jonathan W; Zalsman Gil; Mann J John
Neuropsychological characteristics as predictors of SSRI treatment response in depressed subjects.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(8):1213-9.
2008: Bruder Gerard E; Sedoruk James P; Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M; Tenke Craig E
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings.
Biological psychiatry 2008;63(12):1171-7.
2008: Agosti Vito; Stewart Jonathan W
Hypomania with and without Dysphoria: comparison of comorbidity and clinical characteristics of respondents from a national community sample.
Journal of affective disorders 2008;108(1-2):177-82.
2008: Tenke Craig E; Kayser Jürgen; Shankman Stewart A; Griggs Carlye B; Leite Paul; Stewart Jonathan W; Bruder Gerard E
Hemispatial PCA dissociates temporal from parietal ERP generator patterns: CSD components in healthy adults and depressed patients during a dichotic oddball task.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2008;67(1):1-16.
2007: Trivedi Madhukar H; Rush A John; Gaynes Bradley N; Stewart Jonathan W; Wisniewski Stephen R; Warden Diane; Ritz Louise; Luther James F; Stegman Diane; Deveaugh-Geiss Joanne; Howland Robert
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(12):2479-89.
2007: Zisook Sidney; Lesser Ira; Stewart Jonathan W; Wisniewski Stephen R; Balasubramani G K; Fava Maurizio; Gilmer William S; Dresselhaus Timothy R; Thase Michael E; Nierenberg Andrew A; Trivedi Madhukar H; Rush A John
Effect of age at onset on the course of major depressive disorder.
The American journal of psychiatry 2007;164(10):1539-46.
2007: Bruder Gerard E; Stewart Jonathan W; Schaller Jennifer D; McGrath Patrick J
Predicting therapeutic response to secondary treatment with bupropion: dichotic listening tests of functional brain asymmetry.
Psychiatry research 2007;153(2):137-43.
2007: Agosti Vito; Stewart Jonathan W
Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression.
International clinical psychopharmacology 2007;22(5):309-11.
2007: Warden Diane; Trivedi Madhukar H; Wisniewski Stephen R; Davis Lori; Nierenberg Andrew A; Gaynes Bradley N; Zisook Sidney; Hollon Steven D; Balasubramani G K; Howland Robert; Fava Maurizio; Stewart Jonathan W; Rush A John
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
The American journal of psychiatry 2007;164(8):1189-97.
2007: Stewart Jonathan W; Thase Michael E
Treating DSM-IV depression with atypical features.
The Journal of clinical psychiatry 2007;68(4):e10.
2007: Stewart Jonathan W
Treating depression with atypical features.
The Journal of clinical psychiatry 2007;68 Suppl 3():25-9.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Stewart Jonathan W; Warden Diane; Niederehe George; Thase Michael E; Lavori Philip W; Lebowitz Barry D; McGrath Patrick J; Rosenbaum Jerrold F; Sackeim Harold A; Kupfer David J; Luther James; Fava Maurizio
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.
The American journal of psychiatry 2006;163(11):1905-17.
2006: McGrath Patrick J; Stewart Jonathan W; Quitkin Frederic M; Chen Ying; Alpert Jonathan E; Nierenberg Andrew A; Fava Maurizio; Cheng Jianfeng; Petkova Eva
Predictors of relapse in a prospective study of fluoxetine treatment of major depression.
The American journal of psychiatry 2006;163(9):1542-8.
2006: McGrath Patrick J; Stewart Jonathan W; Fava Maurizio; Trivedi Madhukar H; Wisniewski Stephen R; Nierenberg Andrew A; Thase Michael E; Davis Lori; Biggs Melanie M; Shores-Wilson Kathy; Luther James F; Niederehe George; Warden Diane; Rush A John
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
The American journal of psychiatry 2006;163(9):1531-41; quiz 1666.
2006: Rush A John; Trivedi Madhukar H; Wisniewski Stephen R; Stewart Jonathan W; Nierenberg Andrew A; Thase Michael E; Ritz Louise; Biggs Melanie M; Warden Diane; Luther James F; Shores-Wilson Kathy; Niederehe George; Fava Maurizio;
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
The New England journal of medicine 2006;354(12):1231-42.
2006: Taylor Bonnie P; Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Halperin Jeffrey; Ehrlichman Howard; Quitkin Frederic M
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients.
The American journal of psychiatry 2006;163(1):73-8.
2005: Novick Jon S; Stewart Jonathan W; Wisniewski Stephen R; Cook Ian A; Manev Radmila; Nierenberg Andrew A; Rosenbaum Jerrold F; Shores-Wilson Kathy; Balasubramani G K; Biggs Melanie M; Zisook Sid; Rush A John;
Clinical and demographic features of atypical depression in outpatients with major depressive disorder: preliminary findings from STAR*D.
The Journal of clinical psychiatry 2005;66(8):1002-11.
2005: Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W; Deliyannides Deborah; Taylor Bonnie P; Davies Carrie A; Klein Donald F
Remission rates with 3 consecutive antidepressant trials: effectiveness for depressed outpatients.
The Journal of clinical psychiatry 2005;66(6):670-6.
2005: Stewart Jonathan W; Quitkin Frederic M; McGrath Patrick J; Klein Donald F
Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
Journal of affective disorders 2005;86(2-3):161-7.
2005: Taylor Bonnie P; Quitkin Frederic M; McGrath Patrick J; Stewart Jonathan W
Do antihypertensives make tranylcypromine safer? Three case reports.
The Journal of clinical psychiatry 2005;66(5):657-8.
2004: Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Deliyannides Deborah; Quitkin Frederic M
Dichotic listening tests of functional brain asymmetry predict response to fluoxetine in depressed women and men.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(9):1752-61.
2004: Rush A John; Fava Maurizio; Wisniewski Stephen R; Lavori Philip W; Trivedi Madhukar H; Sackeim Harold A; Thase Michael E; Nierenberg Andrew A; Quitkin Frederic M; Kashner T Michael; Kupfer David J; Rosenbaum Jerrold F; Alpert Jonathan; Stewart Jonathan W; McGrath Patrick J; Biggs Melanie M; Shores-Wilson Kathy; Lebowitz Barry D; Ritz Louise; Niederehe George;
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
Controlled clinical trials 2004;25(1):119-42.
2004: Bruder Gerard E; Schneier Franklin R; Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic
Left hemisphere dysfunction during verbal dichotic listening tests in patients who have social phobia with or without comorbid depressive disorder.
The American journal of psychiatry 2004;161(1):72-8.
2003: Donovan Stephen J; Nunes Edward V; Stewart Jonathan W; Ross Don; Quitkin Frederic M; Jensen Peter S; Klein Donald F
"Outer-directed irritability": a distinct mood syndrome in explosive youth with a disruptive behavior disorder?
The Journal of clinical psychiatry 2003;64(6):698-701.
2003: Stewart Jonathan W; Bruder Gerard E; McGrath Patrick J; Quitkin Frederic M
Do age of onset and course of illness define biologically distinct groups within atypical depression?
Journal of abnormal psychology 2003;112(2):253-62.
2002: Quitkin Frederic M; Stewart Jonathan W; McGrath Patrick J; Taylor Bonnie P; Tisminetzky Mayra S; Petkova Eva; Chen Ying; Ma Guoguang; Klein Donald F
Are there differences between women's and men's antidepressant responses?
The American journal of psychiatry 2002;159(11):1848-54.
2002: Agosti V; Quitkin F M; Stewart J W; McGrath P J
Somatization as a predictor of medication discontinuation due to adverse events.
International clinical psychopharmacology 2002;17(6):311-4.
2002: Bruder Gerard E; Stewart Jonathan W; McGrath Patrick J; Ma Guoguang Julie; Wexler Bruce E; Quitkin Frederic M
Atypical depression: enhanced right hemispheric dominance for perceiving emotional chimeric faces.
Journal of abnormal psychology 2002;111(3):446-54.
2002: Bruder Gerard E; Kayser Jürgen; Tenke Craig E; Leite Paul; Schneier Franklin R; Stewart Jonathan W; Quitkin Frederic M
Cognitive ERPs in depressive and anxiety disorders during tonal and phonetic oddball tasks.
Clinical EEG (electroencephalography) 2002;33(3):119-24.
2002: Stewart Jonathan W; McGrath Patrick J; Quitkin Frederic M
Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2002;26(2):237-45.
2001: Agosti V; Stewart J W
Atypical and non-atypical subtypes of depression: comparison of social functioning, symptoms, course of illness, co-morbidity and demographic features.
Journal of affective disorders 2001;65(1):75-9.
2001: Bruder G E; Stewart J W; Tenke C E; McGrath P J; Leite P; Bhattacharya N; Quitkin F M
Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant.
Biological psychiatry 2001;49(5):416-25.
2000: McGrath P J; Stewart J W; Petkova E; Quitkin F M; Amsterdam J D; Fawcett J; Reimherr F W; Rosenbaum J F; Beasley C M
Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression.
The Journal of clinical psychiatry 2000;61(7):518-24.
2000: Petkova E; Quitkin F M; McGrath P J; Stewart J W; Klein D F
A method to quantify rater bias in antidepressant trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(6):559-65.
2000: Donovan S J; Stewart J W; Nunes E V; Quitkin F M; Parides M; Daniel W; Susser E; Klein D F
Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design.
The American journal of psychiatry 2000;157(5):818-20.
2000: McGrath P J; Stewart J W; Janal M N; Petkova E; Quitkin F M; Klein D F
A placebo-controlled study of fluoxetine versus imipramine in the acute treatment of atypical depression.
The American journal of psychiatry 2000;157(3):344-50.
1999: Stewart J W; Quitkin F M; McGrath P J; Bruder G E
Do tricyclic responders have different brain laterality?
Journal of abnormal psychology 1999;108(4):707-10.
1999: Bruder G E; Wexler B E; Stewart J W; Price L H; Quitkin F M
Perceptual asymmetry differences between major depression with or without a comorbid anxiety disorder: a dichotic listening study.
Journal of abnormal psychology 1999;108(2):233-9.
1999: Bruder G E; Tenke C E; Stewart J W; McGrath P J; Quitkin F M
Predictors of therapeutic response to treatments for depression: a review of electrophysiologic and dichotic listening studies.
CNS spectrums 1999;4(8):30-6.
1998: Stewart J W; Garfinkel R; Nunes E V; Donovan S; Klein D F
Atypical features and treatment response in the National Institute of Mental Health Treatment of Depression Collaborative Research Program.
Journal of clinical psychopharmacology 1998;18(6):429-34.
1998: Quitkin F M; McGrath P J; Stewart J W; Ocepek-Welikson K; Taylor B P; Nunes E; Delivannides D; Agosti V; Donovan S J; Ross D; Petkova E; Klein D F
Placebo run-in period in studies of depressive disorders. Clinical, heuristic and research implications.
The British journal of psychiatry : the journal of mental science 1998;173():242-8.
1998: Agosti V; Stewart J W
Social functioning and residual symptomatology among outpatients who responded to treatment and recovered from major depression.
Journal of affective disorders 1998;47(1-3):207-10.
1997: Bruder G E; Stewart J W; Mercier M A; Agosti V; Leite P; Donovan S; Quitkin F M
Outcome of cognitive-behavioral therapy for depression: relation to hemispheric dominance for verbal processing.
Journal of abnormal psychology 1997;106(1):138-44.
1997: Donovan S J; Susser E S; Nunes E V; Stewart J W; Quitkin F M; Klein D F
Divalproex treatment of disruptive adolescents: a report of 10 cases.
The Journal of clinical psychiatry 1997;58(1):12-5.
1996: Quitkin F M; McGrath P J; Stewart J W; Taylor B P; Klein D F
Can the effects of antidepressants be observed in the first two weeks of treatment?
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(4):390-4.
1996: Quitkin F M; McGrath P J; Stewart J W; Ocepek-Welikson K; Taylor B P; Nunes E; Deliyannides D; Agosti V; Donovan S J; Petkova E; Klein D F
Chronological milestones to guide drug change. When should clinicians switch antidepressants?
Archives of general psychiatry 1996;53(9):785-92.
1996: Bruder G E; Otto M W; McGrath P J; Stewart J W; Fava M; Rosenbaum J F; Quitkin F M
Dichotic listening before and after fluoxetine treatment for major depression: relations of laterality to therapeutic response.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(2):171-9.
1996: McGrath P J; Nunes E V; Stewart J W; Goldman D; Agosti V; Ocepek-Welikson K; Quitkin F M
Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial.
Archives of general psychiatry 1996;53(3):232-40.
1995: Nunes E V; McGrath P J; Quitkin F M; Ocepek-Welikson K; Stewart J W; Koenig T; Wager S; Klein D F
Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
Drug and alcohol dependence 1995;39(3):185-95.
1995: Bruder G E; Tenke C E; Stewart J W; Towey J P; Leite P; Voglmaier M; Quitkin F M
Brain event-related potentials to complex tones in depressed patients: relations to perceptual asymmetry and clinical features.
Psychophysiology 1995;32(4):373-81.
1994: McGrath P J; Stewart J W; Quitkin F M; Wager S; Jenkins S W; Archibald D G; Stringfellow J C; Robinson D S
Gepirone treatment of atypical depression: preliminary evidence of serotonergic involvement.
Journal of clinical psychopharmacology 1994;14(5):347-52.
1994: McGrath P J; Stewart J W; Nunes E N; Quitkin F M
Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
The Journal of clinical psychiatry 1994;55(8):336-9.
1994: Donovan S J; Quitkin F M; Stewart J W; Ocepek-Welikson K; Harrison W; McGrath P J; Nunes E V; Wager S; Tricamo E
Duration of antidepressant trials: clinical and research implications.
Journal of clinical psychopharmacology 1994;14(1):64-6.
1994: Rothschild R; Quitkin H M; Quitkin F M; Stewart J W; Ocepek-Welikson K; McGrath P J; Tricamo E
A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
The International journal of eating disorders 1994;15(1):1-9.
1993: Stewart J W; McGrath P J; Quitkin F M; Rabkin J G; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
Chronic depression: response to placebo, imipramine, and phenelzine.
Journal of clinical psychopharmacology 1993;13(6):391-6.
1993: Stewart J W; McGrath P J; Rabkin J G; Quitkin F M
Atypical depression. A valid clinical entity?
The Psychiatric clinics of North America 1993;16(3):479-95.
1993: Quitkin F M; Stewart J W; McGrath P J; Tricamo E; Rabkin J G; Ocepek-Welikson K; Nunes E; Harrison W; Klein D F
Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
The British journal of psychiatry. Supplement 1993;(21):30-4.
1993: McGrath P J; Stewart J W; Tricamo E; Nunes E N; Quitkin F M
Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
Journal of clinical psychopharmacology 1993;13(3):224-5.
1993: Agosti V; Stewart J W; Quitkin F M; Ocepek-Welikson K
How symptomatic do depressed patients remain after benefiting from medication treatment?
Comprehensive psychiatry 1993;34(3):182-6.
1993: Quitkin F M; Stewart J W; McGrath P J; Nunes E; Ocepek-Welikson K; Tricamo E; Rabkin J G; Klein D F
Further evidence that a placebo response to antidepressants can be identified.
The American journal of psychiatry 1993;150(4):566-70.
1993: Quitkin F M; Stewart J W; McGrath P J; Nunes E; Ocepek-Welikson K; Tricamo E; Rabkin J G; Ross D; Klein D F
Loss of drug effects during continuation therapy.
The American journal of psychiatry 1993;150(4):562-5.
1993: Stewart J W; Mercier M A; Agosti V; Guardino M; Quitkin F M
Imipramine is effective after unsuccessful cognitive therapy: sequential use of cognitive therapy and imipramine in depressed outpatients.
Journal of clinical psychopharmacology 1993;13(2):114-9.
1993: McGrath P J; Stewart J W; Nunes E V; Ocepek-Welikson K; Rabkin J G; Quitkin F M; Klein D F
A double-blind crossover trial of imipramine and phenelzine for outpatients with treatment-refractory depression.
The American journal of psychiatry 1993;150(1):118-23.
1992: Bruder G E; Stewart J W; Towey J P; Friedman D; Tenke C E; Voglmaier M M; Leite P; Cohen P; Quitkin F M
Abnormal cerebral laterality in bipolar depression: convergence of behavioral and brain event-related potential findings.
Biological psychiatry 1992;32(1):33-47.
1992: McGrath P J; Stewart J W; Harrison W M; Ocepek-Welikson K; Rabkin J G; Nunes E N; Wager S G; Tricamo E; Quitkin F M; Klein D F
Predictive value of symptoms of atypical depression for differential drug treatment outcome.
Journal of clinical psychopharmacology 1992;12(3):197-202.
1992: Mercier M A; Stewart J W; Quitkin F M
A pilot sequential study of cognitive therapy and pharmacotherapy of atypical depression.
The Journal of clinical psychiatry 1992;53(5):166-70.
1992: Stewart J W; McGrath P J; Quitkin F M
Can mildly depressed outpatients with atypical depression benefit from antidepressants?
The American journal of psychiatry 1992;149(5):615-9.
1992: Stewart J W; Quitkin F M; Klein D F
The pharmacotherapy of minor depression.
American journal of psychotherapy 1992;46(1):23-36.
1991: Agosti V; Stewart J W; Quitkin F M
Life satisfaction and psychosocial functioning in chronic depression: effect of acute treatment with antidepressants.
Journal of affective disorders 1991;23(1):35-41.
1991: Bruder G E; Towey J P; Stewart J W; Friedman D; Tenke C; Quitkin F M
Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency.
Biological psychiatry 1991;30(3):233-46.
1991: Nunes E V; Quitkin F M; Brady R; Stewart J W
Imipramine treatment of methadone maintenance patients with affective disorder and illicit drug use.
The American journal of psychiatry 1991;148(5):667-9.
1991: Quitkin F M; Harrison W; Stewart J W; McGrath P J; Tricamo E; Ocepek-Welikson K; Rabkin J G; Wager S G; Nunes E; Klein D F
Response to phenelzine and imipramine in placebo nonresponders with atypical depression. A new application of the crossover design.
Archives of general psychiatry 1991;48(4):319-23.
1991: Agosti V; Nunes E; Stewart J W; Quitkin F M
Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report.
The International journal of the addictions 1991;26(3):327-34.
1991: Quitkin F M; McGrath P J; Rabkin J G; Stewart J W; Harrison W; Ross D C; Tricamo E; Fleiss J; Markowitz J; Klein D F
Different types of placebo response in patients receiving antidepressants.
The American journal of psychiatry 1991;148(2):197-203.
1991: Quitkin F M; Rabkin J G; Stewart J W; McGrath P J; Harrison W; Ross D C; Tricamo E; Fleiss J; Markowitz J; Klein D F
Heterogeneity of clinical response during placebo treatment.
The American journal of psychiatry 1991;148(2):193-6.
1990: Rabkin J G; McGrath P J; Quitkin F M; Tricamo E; Stewart J W; Klein D F
Effects of pill-giving on maintenance of placebo response in patients with chronic mild depression.
The American journal of psychiatry 1990;147(12):1622-6.
1990: Quitkin F M; McGrath P J; Stewart J W; Harrison W; Tricamo E; Wager S G; Ocepek-Welikson K; Nunes E; Rabkin J G; Klein D F
Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
Archives of general psychiatry 1990;47(10):935-41.
1990: Stewart J W; Quitkin F M; Terman M; Terman J S
Is seasonal affective disorder a variant of atypical depression? Differential response to light therapy.
Psychiatry research 1990;33(2):121-8.
1990: Bruder G E; Stewart J W; Voglmaier M M; Harrison W M; McGrath P; Tricamo E; Quitkin F M
Cerebral laterality and depression: relations of perceptual asymmetry to outcome of treatment with tricyclic antidepressants.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1990;3(1):1-10.
1989: Stewart J W; McGrath P J; Quitkin F M; Harrison W; Markowitz J; Wager S; Leibowitz M R
Relevance of DMS-III depressive subtype and chronicity of antidepressant efficacy in atypical depression. Differential response to phenelzine, imipramine, and placebo.
Archives of general psychiatry 1989;46(12):1080-7.
1989: Quitkin F M; McGrath P J; Stewart J W; Harrison W; Wager S G; Nunes E; Rabkin J G; Tricamo E; Markowitz J; Klein D F
Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
Archives of general psychiatry 1989;46(9):787-93.
1989: Bruder G E; Quitkin F M; Stewart J W; Martin C; Voglmaier M M; Harrison W M
Cerebral laterality and depression: differences in perceptual asymmetry among diagnostic subtypes.
Journal of abnormal psychology 1989;98(2):177-86.
1989: Terman M; Terman J S; Quitkin F M; McGrath P J; Stewart J W; Rafferty B
Light therapy for seasonal affective disorder. A review of efficacy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1989;2(1):1-22.
1989: Harrison W M; McGrath P J; Stewart J W; Quitkin F
MAOIs and hypertensive crises: the role of OTC drugs.
The Journal of clinical psychiatry 1989;50(2):64-5.
1989: Stewart J W; Halbreich U
Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication.
Biological psychiatry 1989;25(1):33-8.
1989: Parsons B; Quitkin F M; McGrath P J; Stewart J W; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin J G; Wager S G; Nunes E
Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
Psychopharmacology bulletin 1989;25(4):524-34.
1989: McGrath P J; Stewart J W; Harrison W; Wager S; Nunes E N; Quitkin F M
A placebo-controlled trial of L-deprenyl in atypical depression.
Psychopharmacology bulletin 1989;25(1):63-7.
1988: Stewart J W; Quitkin F M; McGrath P J; Rabkin J G; Markowitz J S; Tricamo E; Klein D F
Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment.
Psychiatry research 1988;25(2):213-22.
1988: McGrath P J; Stewart J W; Liebowitz M R; Markowitz J M; Quitkin F M; Klein D F; Gorman J M
Lactate provocation of panic attacks in depressed outpatients.
Psychiatry research 1988;25(1):41-7.
1988: Agosti V; Stewart J W; Quitkin F M; Rabkin J G; McGrath P J; Markowitz J
Factors associated with premature medication discontinuation among responders to an MAOI or a tricyclic antidepressant.
The Journal of clinical psychiatry 1988;49(5):196-8.
1988: Quitkin F M; Stewart J W; McGrath P J; Liebowitz M R; Harrison W M; Tricamo E; Klein D F; Rabkin J G; Markowitz J S; Wager S G
Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
The American journal of psychiatry 1988;145(3):306-11.
1988: Liebowitz M R; Quitkin F M; Stewart J W; McGrath P J; Harrison W M; Markowitz J S; Rabkin J G; Tricamo E; Goetz D M; Klein D F
Antidepressant specificity in atypical depression.
Archives of general psychiatry 1988;45(2):129-37.
1988: Terman M; Terman J S; Quitkin F M; Cooper T B; Lo E S; Gorman J M; Stewart J W; McGrath P J
Response of the melatonin cycle to phototherapy for Seasonal Affective Disorder. Short note.
Journal of neural transmission 1988;72(2):147-65.
1987: McGrath P J; Blood D K; Stewart J W; Harrison W; Quitkin F M; Tricamo E; Markowitz J
A comparative study of the electrocardiographic effects of phenelzine, tricyclic antidepressants, mianserin, and placebo.
Journal of clinical psychopharmacology 1987;7(5):335-9.
1987: Terman M; Quitkin F M; Terman J S; Stewart J W; McGrath P J
The timing of phototherapy: effects on clinical response and the melatonin cycle.
Psychopharmacology bulletin 1987;23(3):354-7.
1986: Rabkin J G; McGrath P; Stewart J W; Harrison W; Markowitz J S; Quitkin F
Follow-up of patients who improved during placebo washout.
Journal of clinical psychopharmacology 1986;6(5):274-8.
1986: Harrison W M; Rabkin J G; Ehrhardt A A; Stewart J W; McGrath P J; Ross D; Quitkin F M
Effects of antidepressant medication on sexual function: a controlled study.
Journal of clinical psychopharmacology 1986;6(3):144-9.
1984: Harrison W M; Cooper T B; Stewart J W; Quitkin F M; McGrath P J; Liebowitz M R; Rabkin J R; Markowitz J S; Klein D F
The tyramine challenge test as a marker for melancholia.
Archives of general psychiatry 1984;41(7):681-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jonathan Stewart

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Devices

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jonathan Stewart (preview)

All Publications